Emergency hospitalizations for adverse drug events in older Americans
- PMID: 22111719
- DOI: 10.1056/NEJMsa1103053
Emergency hospitalizations for adverse drug events in older Americans
Abstract
Background: Adverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse drug events that result in hospitalization in this population have been limited.
Methods: We used adverse-event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2007 through 2009) to estimate the frequency and rates of hospitalization after emergency department visits for adverse drug events in older adults and to assess the contribution of specific medications, including those identified as high-risk or potentially inappropriate by national quality measures.
Results: On the basis of 5077 cases identified in our sample, there were an estimated 99,628 emergency hospitalizations (95% confidence interval [CI], 55,531 to 143,724) for adverse drug events in U.S. adults 65 years of age or older each year from 2007 through 2009. Nearly half of these hospitalizations were among adults 80 years of age or older (48.1%; 95% CI, 44.6 to 51.6). Nearly two thirds of hospitalizations were due to unintentional overdoses (65.7%; 95% CI, 60.1 to 71.3). Four medications or medication classes were implicated alone or in combination in 67.0% (95% CI, 60.0 to 74.1) of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). High-risk medications were implicated in only 1.2% (95% CI, 0.7 to 1.7) of hospitalizations.
Conclusions: Most emergency hospitalizations for recognized adverse drug events in older adults resulted from a few commonly used medications, and relatively few resulted from medications typically designated as high-risk or inappropriate. Improved management of antithrombotic and antidiabetic drugs has the potential to reduce hospitalizations for adverse drug events in older adults.
Comment in
-
Emergency hospitalizations for adverse drug events.N Engl J Med. 2012 Mar 1;366(9):858-9; author reply 859-60. doi: 10.1056/NEJMc1114768. N Engl J Med. 2012. PMID: 22375984 No abstract available.
-
Emergency hospitalizations for adverse drug events.N Engl J Med. 2012 Mar 1;366(9):859; author reply 859-60. doi: 10.1056/NEJMc1114768. N Engl J Med. 2012. PMID: 22375985 No abstract available.
-
[Four drug groups cause two thirds of all adverse drug effect-induced emergency hospitalizations in the elderly].Praxis (Bern 1994). 2012 Apr 11;101(8):549-50. doi: 10.1024/1661-8157/a000894. Praxis (Bern 1994). 2012. PMID: 22492077 German. No abstract available.
Similar articles
-
Medication overdoses leading to emergency department visits among children.Am J Prev Med. 2009 Sep;37(3):181-7. doi: 10.1016/j.amepre.2009.05.018. Am J Prev Med. 2009. PMID: 19666156
-
Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.Ann Emerg Med. 2005 Feb;45(2):197-206. doi: 10.1016/j.annemergmed.2004.09.020. Ann Emerg Med. 2005. PMID: 15671977
-
National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.J Pediatr. 2008 Mar;152(3):416-21. doi: 10.1016/j.jpeds.2007.07.041. Epub 2007 Oct 22. J Pediatr. 2008. PMID: 18280852
-
Adverse drug events as a cause of hospitalization in older adults.Drug Saf. 2012 Jan;35 Suppl 1:29-45. doi: 10.1007/BF03319101. Drug Saf. 2012. PMID: 23446784 Review.
-
[Adverse drug events of older patients presenting in the emergency department].Ther Umsch. 2015 Dec;72(11-12):673-7. doi: 10.1024/0040-5930/a000736. Ther Umsch. 2015. PMID: 26654810 Review. German.
Cited by
-
Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review.Pharmaceuticals (Basel). 2023 Nov 1;16(11):1542. doi: 10.3390/ph16111542. Pharmaceuticals (Basel). 2023. PMID: 38004408 Free PMC article. Review.
-
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.Pharmacogenomics. 2012 Dec;13(16):1925-35. doi: 10.2217/pgs.12.164. Pharmacogenomics. 2012. PMID: 23215885 Free PMC article.
-
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure.Drugs Aging. 2013 Aug;30(8):645-54. doi: 10.1007/s40266-013-0086-8. Drugs Aging. 2013. PMID: 23645530 Free PMC article.
-
Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients.Saudi Med J. 2016 Apr;37(4):361-8. doi: 10.15537/smj.2016.4.14036. Saudi Med J. 2016. PMID: 27052278 Free PMC article. Review.
-
Therapeutic ranges of serum digoxin concentrations in patients with heart failure.Am J Cardiol. 2012 Jun 15;109(12):1818-21. doi: 10.1016/j.amjcard.2012.02.028. Epub 2012 Apr 11. Am J Cardiol. 2012. PMID: 22502901 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical